Home/Filings/4/0001847903-23-000161
4//SEC Filing

Rotman Harris 4

Accession 0001847903-23-000161

CIK 0001847903other

Filed

Sep 21, 8:00 PM ET

Accepted

Sep 22, 4:47 PM ET

Size

13.2 KB

Accession

0001847903-23-000161

Insider Transaction Report

Form 4
Period: 2023-09-20
Rotman Harris
SVP Regulatory Affairs
Transactions
  • Sale

    Ordinary Shares

    2023-09-20$6.29/sh37,484$235,68833,500 total
  • Exercise/Conversion

    Share Option (right to buy)

    2023-09-2031,25093,750 total
    Exercise: $4.47Exp: 2032-08-01Ordinary Shares (31,250 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2023-09-20$4.47/sh+31,250$139,68864,750 total
  • Exercise/Conversion

    Ordinary Shares

    2023-09-20$3.85/sh+6,234$24,00170,984 total
  • Exercise/Conversion

    Share Option (right to buy)

    2023-09-206,23443,666 total
    Exercise: $3.85Exp: 2033-02-01Ordinary Shares (6,234 underlying)
Footnotes (5)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 20, 2023.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.01 to $6.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F4]25% of the shares subject to such option shall vest and become exercisable on August 1, 2023 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
  • [F5]6,234 of the shares vest and become exercisable on August 1, 2023 and 1/48th of the shares subject to such option shall vest and become exercisable in 42 monthly installments on the first day of each month thereafter.

Issuer

Centessa Pharmaceuticals plc

CIK 0001847903

Entity typeother

Related Parties

1
  • filerCIK 0001981420

Filing Metadata

Form type
4
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 4:47 PM ET
Size
13.2 KB